Document Detail

Risk of malignancy index for adnexal masses.
MedLine Citation:
PMID:  19480249     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: The aim of this study was to determine the effectiveness of the risk of malignancy index (RMI) and retrospective analysis of patients presenting with adnexal masses to our clinic for treatment. METHODS: Data of 137 women who had adnexal masses were included in the analysis. A simple algorithm called "risk of malignancy index" (RMI) reported by Jacobs includes menopausal status, ultrasound morphologic features and serum CA125 level. The RMI values were detected for each patient and analyzed to detect the relationship between benign and malign groups of the patients. Statistical analyses were performed with SPSS 15.0 for Windows (SPSS, Inc., Chicago, IL USA). Sensitivity and specificity was calculated for RMI in diagnoses of ovarian cancer by using receiver operating characteristic (ROC) analysis. RESULTS: A total of 137 patients with adnexal masses were operated on. Mean age and SD of 137 patients were 30.64 +/- 10.05. Fourteen patients (10.2%) had malignant disease and 123 patients (89.8%) benign pathology. ROC analysis of the RMI showed that the values of area under the curve were significantly high with a value of 0.883 (p < 0.001). CONCLUSION: The RMI is a simple scoring system and has a high sensitivity and specificity for the detection of malignant adnexal masses. Application of the RMI in clinical practice may provide a rational basis for specialists to treat patients with adnexal masses before diagnostic surgery.
N Akdeniz; U Kuyumcuoğlu; A Kale; M Erdemoğlu; F Caca
Related Documents :
11515619 - The outcome in myasthenia gravis patients--an eight-year follow-up after finishing immu...
12821509 - Clinical correlates with anti-musk antibodies in generalized seronegative myasthenia gr...
22815079 - Anticholinesterase-induced symptoms improved by pacemaker implantation in patients with...
17522949 - The role of malignancies in patients with catastrophic anti-phospholipid (asherson's) s...
6402089 - Hla antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia ...
12130459 - Mucosa-associated lymphoid tissue lymphoma in sjögren's syndrome: initial and follow-u...
20374299 - Portal vein thrombosis in egyptian patients with liver cirrhosis: role of methylenetetr...
16877989 - Evaluation of cardiac function by tissue doppler imaging in children with chronic hepat...
6605119 - Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of gynaecological oncology     Volume:  30     ISSN:  0392-2936     ISO Abbreviation:  Eur. J. Gynaecol. Oncol.     Publication Date:  2009  
Date Detail:
Created Date:  2009-06-01     Completed Date:  2009-06-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8100357     Medline TA:  Eur J Gynaecol Oncol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  178-80     Citation Subset:  IM    
Department of Obstetrics and Gynecology, Dicle University, Diyarbakir, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adnexa Uteri / ultrasonography
Adnexal Diseases / diagnosis*
CA-125 Antigen / blood
Genital Neoplasms, Female / diagnosis*
Ovarian Neoplasms / diagnosis
ROC Curve
Risk Assessment
Sensitivity and Specificity
Tumor Markers, Biological / blood
Young Adult
Reg. No./Substance:
0/CA-125 Antigen; 0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Metastatic involvement of the urinary tract in patients with advanced ovarian carcinoma: lessons fro...
Next Document:  Genetic imbalance related to cisplatin-based chemoresistance in epithelial ovarian cancer.